Biotech Patent War Could Triple Damages

Harbour BioMed just scored a massive win against Amgen. Jury says $20.2M in damages, but it could triple. Why? Willful infringement. And they’re not done—another patent fight looms, potentially 10 times bigger. What’s next in this high-stakes battle for antibody tech dominance?

IBM's betting $10B on quantum computing. Bold move or risky gamble? They're teaming with Google and launching AI initiatives. Aiming to reshape enterprise tech. But can this quantum leap offset legacy pressures? Or will client hesitations slow them down? The stakes are high. What's IBM's next strategic play?

AT&T slashes fiber prices. Just $35 a month with bundles. New entry-level 300 Mbps is triple the speed. But here’s the kicker: satellite LEOs are circling. Oppenheimer downgrades AT&T. Can they outpace the stars or face a cosmic squeeze?